Document Detail


Comparison of gadobenate dimeglumine-enhanced dynamic MRI and 16-MDCT for the detection of hepatocellular carcinoma.
MedLine Citation:
PMID:  16357395     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: The objective of our study was to compare the diagnostic performance of gadobenate dimeglumine-enhanced MRI with that of 16-MDCT for the detection of hepatocellular carcinoma using receiver operating characteristic (ROC) curve analysis. MATERIALS AND METHODS: Thirty-one patients with 53 hepatocellular carcinomas underwent gadobenate dimeglumine-enhanced dynamic MRI and multiphasic CT using 16-MDCT within a mean interval of 5 days (range, 3-9 days). The dynamic MRI examination was performed using 3D fat-saturated volumetric interpolated imaging and sensitivity encoding on a 1.5-T unit. Both dynamic MRI and multiphasic MDCT included dual arterial phase images. Three observers independently interpreted the CT and MR images in random order, separately, and without patient identifiers. The diagnostic accuracy of each technique was evaluated using the alternative-free response ROC method. The sensitivity and positive predictive values were also calculated. RESULTS: The sensitivities of gadobenate dimeglumine-enhanced MRI for all observers were significantly higher than those of MDCT for all the lesions and for lesions 1.0 cm or smaller (p < 0.05); however, for lesions larger than 1.0 cm, the sensitivities of the two imaging techniques were similar. The mean area under the ROC curve (A(z)) of gadobenate dimeglumine-enhanced MRI (0.87 +/- 0.03 [SD]) was higher than that of MDCT (0.83 +/- 0.04), but no significant difference was found between them (p = 0.31). The number of false-positive findings on dynamic MRI was slightly higher than on MDCT, but no significant difference in the positive predictive value between the two imaging techniques was detected (observer 1, p = 0.06; observer 2, p = 0.13; observer 3, p = 1.00). CONCLUSION: Gadobenate dimeglumine-enhanced MRI has a higher sensitivity for small hepatocellular carcinomas (</= 1 cm) but a higher false-positive rate due to nonspecific enhancement of benign lesions, such as arterioportal shunt, leading to no significant difference of overall accuracy when compared with MDCT.
Authors:
Young Kon Kim; Chong Soo Kim; Gyong Ho Chung; Young-Min Han; Sang Yong Lee; Su Bin Chon; Jeong Min Lee
Related Documents :
11350285 - Dynamic contrast-enhanced mr imaging in symptomatic bone stress of the pelvis and the l...
10701605 - Dynamic mr imaging of the pelvic floor in asymptomatic subjects.
10229535 - Cervical myelopathy due to dynamic compression by the laminectomy membrane: dynamic mr ...
16636515 - Dynamic computed tomography myelography for the investigation of cervical degenerative ...
7683125 - Proton radiation therapy for clivus chordoma--case report.
1282835 - Preretinal neovascularization in diabetic retinopathy: a preliminary investigation usin...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  AJR. American journal of roentgenology     Volume:  186     ISSN:  0361-803X     ISO Abbreviation:  AJR Am J Roentgenol     Publication Date:  2006 Jan 
Date Detail:
Created Date:  2005-12-16     Completed Date:  2006-02-16     Revised Date:  2008-02-15    
Medline Journal Info:
Nlm Unique ID:  7708173     Medline TA:  AJR Am J Roentgenol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  149-57     Citation Subset:  AIM; IM    
Affiliation:
Department of Diagnostic Radiography, Chonbuk National University Hospital and Medical School, Jeonju, South Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Carcinoma, Hepatocellular / diagnosis*,  radiography
Contrast Media*
Female
Gadolinium DTPA / diagnostic use*
Humans
Infant, Newborn
Liver Neoplasms / diagnosis*,  radiography
Magnetic Resonance Imaging*
Male
Middle Aged
Predictive Value of Tests
ROC Curve
Sensitivity and Specificity
Tomography, X-Ray Computed*
Chemical
Reg. No./Substance:
0/Contrast Media; 80529-93-7/Gadolinium DTPA

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Ferumoxtran-10-enhanced MR lymphangiography: does contrast-enhanced imaging alone suffice for accura...
Next Document:  Importance of evaluating all vascular phases on contrast-enhanced sonography in the differentiation ...